μεεϊψιν ϊξιρδ

φεψϊ ξϊο

PER OS

ξιπεο

Solution (oral)

ωιξεω αϊψετδ

Levetrim Solution is indicated as:- monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients from 16 years of age with newly diagnosed epilepsy. - adjunctive therapy:in the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 years of age with epilepsy.In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with Juvenile Myoclonic Epilepsy. in the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age with Idiopathic Generalised Epilepsy

ξρτψ ψιωεν

150 58 33779 00

ιφψο

Trima Israel Pharmaceutical Products Maabarot Ltd, Israel

ϊεχσ ψιωιεο μϊψετδ

08/2013 - 07/2018

• δηξψδ μςμεο μφψλο
• ςμεο μφψλο

δερτϊ ϊβεαδ ηγωδ ων * λεϊψϊ * ςζεψ μπε μεεγΰ ωΰϊδ μΰ ψεαεθ δϊβεαδ ωμκ χιωεψιν ιδτλε αΰετο ΰεθεξθι μμηιφιν   αωμιηϊ ϊβεαδ ΰπι ξχαμ ΰϊ ϊπΰι δωιξεω αΰϊψ.